CIAM
ATRA icon

Caitong International Asset Management’s Atara Biotherapeutics ATRA Stock Holding History

Caitong International Asset Management’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.57K Buy
+311
New +$2.48K ﹤0.01% 1330

Other funds holding ATRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.66B AUM 33.26% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
KFP
Kerr Financial Planning Fresno, California $89.6M AUM 72.71% 1-Year Est. Return

Caitong International Asset Management's ATRA Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Atara Biotherapeutics (ATRA) in Q2 2026: 311 shares worth $3.57K. The stake represents ﹤0.01% of the portfolio and ranks #1330 among its holdings.

7 funds tracked by Wall St. Rank hold ATRA as of Q2 2026.

  • Caitong International Asset Management held 311 shares of Atara Biotherapeutics worth $3.57K as of Q2 2026.
  • Atara Biotherapeutics was a new Caitong International Asset Management position in Q2 2026.
  • Atara Biotherapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1330 holding.
  • 7 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.